There are 108 resources available
Invited Discussant 1928O and 1929O
Presenter: Daniela Thommen
Session: Proffered Paper - Translational research
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Samra Turajlic
Session: Proffered Paper - Translational research
Resources:
Webcast
Invited Discussant 1930O, 82O, and 1189O
Presenter: Núria López-Bigas
Session: Proffered Paper - Translational research
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Samra Turajlic
Session: Proffered Paper - Translational research
Resources:
Webcast
Invited Discussant LBA69 and LBA70_PR
Presenter: Evandro de Azambuja
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Evandro de Azambuja
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Webcast
Invited Discussant LBA71 and 1670O
Presenter: Benjamin Solomon
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Slides
Webcast
LBA15 - Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)
Presenter: David Miles
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Abstract
Slides
Webcast
LBA16 - IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
Presenter: Leisha Emens
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Abstract
Slides
Webcast
LBA17 - ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC)
Presenter: Aditya Bardia
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Abstract
Slides
Webcast